Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

November 01, 2006 (Vol. 26, No. 19)

Can Pharma & Biotech Foil Counterfeiting?

Plan Ahead and Safeguard Your Product

  • Despite a downturn in FDA investigations into counterfeiting, concerns within the industry have actually increased, fueled by higher threat levels, the value of the products, and their sheer numbers. “Globally, the problem is getting worse,” according to Dave Sayers, market development supervisor for 3M Security Solutions (www.3m.com). “Counterfeiters aren’t ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.